|
|
||||||||
Webb-Waring Institute, University of Colorado Health Sciences Center, Denver, Colorado 80262
External surfaces of cells are normally protected by extracellular superoxide dismutase, SOD3, which binds to polyanions such as heparan sulfate. We constructed a fusion gene encoding a chimeric SOD consisting of the mature human mitochondrial SOD2 plus the COOH-terminal 26-amino acid heparin-binding "tail" from SOD3. This tail is responsible for the enzyme's affinity for endothelial surfaces. The fusion gene was expressed in Escherichia coli, and the fully active enzyme SOD2/3 was purified. Although native SOD2 has no affinity for heparin, SOD2/3 binds to a heparin-agarose column. In a rat model of acute lung injury induced by intratracheal instillation of IL-1, SOD2/3, SOD2, and denatured SOD2/3 showed 92%, 13.8%, and 0% reduction of lung leak, respectively. Only SOD2/3 prevented neutrophil accumulation. In the carrageenan-induced foot edema model in the rat, SOD2/3 reduced edema by 62% (P < 0.003) at a dose in which native SOD2 produced no significant effect. Thus SOD2/3 appears to have properties as a therapeutic anti-inflammatory agent that are greatly superior to other available forms of the enzyme.
inflammation; lung injury; interleukin-1; free radicals; oxidative injury
This article has been cited by other articles:
![]() |
V. V. Shuvaev, M. Christofidou-Solomidou, F. Bhora, K. Laude, H. Cai, S. Dikalov, E. Arguiri, C. C. Solomides, S. M. Albelda, D. G. Harrison, et al. Targeted Detoxification of Selected Reactive Oxygen Species in the Vascular Endothelium J. Pharmacol. Exp. Ther., November 1, 2009; 331(2): 404 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Muro, M. Mateescu, C. Gajewski, M. Robinson, V. R. Muzykantov, and M. Koval Control of intracellular trafficking of ICAM-1-targeted nanocarriers by endothelial Na+/H+ exchanger proteins Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L809 - L817. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chu, A. Alwahdani, S. Iida, D. D. Lund, F. M. Faraci, and D. D. Heistad Vascular Effects of the Human Extracellular Superoxide Dismutase R213G Variant Circulation, August 16, 2005; 112(7): 1047 - 1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Bowler, M. Nicks, K. Tran, G. Tanner, L.-Y. Chang, S. K. Young, and G. S. Worthen Extracellular Superoxide Dismutase Attenuates Lipopolysaccharide-Induced Neutrophilic Inflammation Am. J. Respir. Cell Mol. Biol., October 1, 2004; 31(4): 432 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Bonder, D. Knight, D. Hernandez-Saavedra, J. M. McCord, and P. Kubes Chimeric SOD2/3 inhibits at the endothelial-neutrophil interface to limit vascular dysfunction in ischemia-reperfusion Am J Physiol Gastrointest Liver Physiol, September 1, 2004; 287(3): G676 - G684. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gow and H. Ischiropoulos Super-SOD: superoxide dismutase chimera fights off inflammation Am J Physiol Lung Cell Mol Physiol, June 1, 2003; 284(6): L915 - L916. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |